Established in 2018, Silexon is committed to significantly (up to 90%) improving the efficiency of life science research, reducing costs, and accelerating biotechnology innovation, drug discovery, patent mining, and commercialization using the most advanced artificial intelligence technology.
Launched the first-generation AI model that assisted to screen out several popular lead compounds.
Completed ￥40M Pre-A round fund raise from venture capital firms of MSA China Fund, Turing Ventures, Ascendin Fund and Prosperico Ventures.
Won the Synced Machine Intelligence Awards of "Top 10 Most Promising AI Companies in China".
Established initial 8 strategic cooperation projects leading to inventions in the fields of small molecules, peptides and cell therapies.
Certified as a high-tech enterprise of Jiangsu Province.
Awarded as the "2019 Top 10 Algorithms & Tools in Bioinformatics in China" and "2019 Top 10 Breakthroughs in Bioinformatics in China".
Completed ￥150M Series A fund raise from venture capital firms of Eight Roads, Sequoia Capital, MSA Capital and QC ONE LIMITED.
Awarded as the "Top 10 Enterprises of Computing Pharmaceutical Innovation", "EY-Fudan Most Promising Seed Enterprise", "Top 10 Future Value Areas in Medicine-Biopharma", "China Pharmaceutical Innovation Alliance CN-HEALTHCARE", and "Microsoft Startup Accelerator Program".
“Awarded as a "Technology-oriented Small and Medium Sized Enterprise" in Nanjing, Jiangsu Province.
Introduced suites of tools including Biology Discovery Engine (BDE) and AutoPatent (AP) to the market.
Awarded as the "Member of Shanghai AI Industry Association", "KPMG China's Top 50 Innovative Biotech Companies", and "Best Solution in AI Drug Development".
Listed as "Nanjing Unicorn Enterprise".
BDE.top platform was launched with a series of AI-aided biology discovery products, such as BDE-Pub, BDE-IP, BDE-Bio, BDE-Chem, BDE-Herb, available for life science researchers worldwide to accelerate biotechnology innovation and intellectual property mining, especially in the areas of small molecule, macromolecule / biologics and TCM / herbal drug design, discovery and development.
Patents & Software CRs